Overview Long-Term Study of TS-142 in Patients With Insomnia Status: Not yet recruiting Trial end date: 2024-05-01 Target enrollment: Participant gender: Summary This is a randomized, open-label, multi-center long-term study in patients with insomnia. Phase: Phase 3 Details Lead Sponsor: Taisho Pharmaceutical Co., Ltd.